Cookies on this site

Research into bipolar disorder at Oxford has received a major boost following a £3 million donation from the Page family. The legacy gift will support the development of innovative new treatments as well as improved methods of self-management for those with the condition.

Bipolar tree - side profile of face with green leaves one side and barren  the other

Thought to affect around 1 in every 50 adults, bipolar disorder predominantly impacts mood, causing swings from one extreme to another. Those living with the mental health condition experience episodes of depression and mania – each episode can last for weeks or longer and the highs and lows are often so extreme that they can cause significant distress and difficulty.

Siblings Jane and John Page had a shared interest in supporting research into the disorder, having both felt the impact of inherited mental health conditions during their lives. John began experiencing symptoms of manic depression (now known as bipolar disorder) when he was an adolescent and struggled with it increasingly until his death at the age of 87. A highly intelligent and thoughtful man, he wrote poetry and painted as a means of processing and expressing his feelings about the condition.

The gift from the Page family will support the work of John Geddes, WA Handley Professor of Psychiatry and Director of the NIHR Oxford Health Biomedical Research Centre. Professor Geddes’ research focuses on the development and evaluation of treatments for people with bipolar and mood disorders. He has led several large-scale trials and had a major influence on clinical practice internationally.

As well as funding research into new treatments for bipolar disorder, the gift will enable Professor Geddes and his team to develop the True Colours remote symptom monitoring system.

Read the full story on the University of Oxford Development Office website

Similar stories

Research shows for the first time that standard non-contrast CT scans can be analysed by AI to reveal hidden coronary inflammation

Researchers from 27 institutions across UK, USA, Europe and Australia, led by a team at the University of Oxford, have demonstrated how an AI technology can measure inflammation in the heart’s arteries using low-radiation CT heart scans typically used to measure calcium score.

Five European Research Council (ERC) Synergy Grants awarded to Oxford researchers for ambitious new collaborations

Five Oxford University academics are to co-lead ambitious new research projects backed by European Research Council (ERC) Synergy Grants, part of the EU’s Horizon Europe research and innovation programme. Synergy Grants support groups of two to four outstanding researchers who combine complementary expertise and resources to tackle ambitious scientific challenges that could not be addressed by individual teams alone.

Professor Ole Jensen (Department of Experimental Psychology) and colleagues received €13.6 million to discover when the brain is ready for language and social understanding

The team will use new wearable brain sensors to track cognitive development from before birth to eight years of age.

New 'molecular glue' helps break down antibiotic resistance enzymes in E. coli

Oxford University scientists have discovered a new approach to tackle antimicrobial resistance (AMR), using 'molecular glues' to encourage bacteria to destroy their own resistance-causing enzymes. The study has been published in Angewandte Chemie International Edition.

Stronger immune system may help protect against prostate cancer

Higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer, in a new study led by researchers at the Nuffield Department of Population Health.

The Nuffield Department of Women's & Reproductive Health has published its Biennial Report 2024–26

The Biennial Report 2024–26 highlights two years of research excellence, innovation, collaboration and growth.